✦ LIBER ✦

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

✍ Scribed by Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sato; Ryosuke Tateishi; Takuma Teratani; Shuichiro Shiina; Masao Omata

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 207 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21832

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined intraarterial 5-fluorouracil an

Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

✍ Masato Sakon; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Akira Y 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Combined therapy consisting of intraarte

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

✍ Young-Hwa Chung; Il Han Song; Byung-Cheol Song; Geun Chan Lee; Moon Soo Koh; Hyu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## BACKGROUND. Hepatocellular carcinoma (HCC) patients with major vascular involvement or extrahepatic metastasis are not good candidates for surgery or transarterial chemoembolization (TACE). In this study, the authors evaluated the efficacy of combined therapy with intraarterial cisplatin infusio

Interferon-α and 5-fluorouracil combinat

Interferon-α and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules

✍ Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Hideo Ota; Shigeru Marubashi; Yu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. The authors reported previously the beneficial effects of interferon (IFN)‐α/5‐fluorouracil (5‐FU) combination therapy for patients with advanced hepatocellular carcinoma (HCC) who have tumor thrombi in the major portal branches. In this report, the authors describe the

Sakon M, Nagano H, Dono K, Nakamori S, U

Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M. Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer. 2002;94(2):435–42.

📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

## Abstract The original article to which this Erratum refers was published in Cancer (2002) 94(2):435–42

Evaluation of 96-hour infusion fluoroura

Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck. A southwest oncology group study

✍ Maha Hussain; Jacqueline Benedetti; Roy E. Smith; Gladys I. Rodriguez; David Sch 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views